Skip to main navigation Skip to search Skip to main content

Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance

  • J M Simons*
  • , A J G Maaskant-Braat
  • , E J T Luiten
  • , M H Leidenius
  • , T J A van Nijnatten
  • , P G Boelens
  • , L B Koppert
  • , C C van der Pol
  • , C J H van de Velde
  • , R A Audisio
  • , M L Smidt
  • *Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)218-219
Number of pages2
JournalEuropean Journal of Surgical Oncology
Volume46
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Axilla
  • Humans
  • Neoadjuvant Therapy
  • Sentinel Lymph Node Biopsy
  • Specialization
  • Surveys and Questionnaires
  • Axillary staging
  • Node-positive
  • Breast cancer
  • Treatment-response
  • Axillary lymph node dissection
  • Neoadjuvant systemic therapy

Cite this